MyBlueDotsATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV MyBlueDots5 months ago01 mins MANASSAS, Va.–(BUSINESS WIRE)– #CancerResearch–ATCC has been awarded a five-year, IDIQ contract by NCI to provide lab services to support AMRVS with research and vaccine development. Post navigation Previous: XiFin Celebrates National Pharmacist Day with Early Insights From 2025 Pharmacy SurveyNext: Montecito Medical Named Key Influencer in Healthcare Real Estate
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots2 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots2 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots2 days ago 0